XNCR Q1 2017 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$861M

Q1 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M-40.2% YoY

Gross Profit

-$11M-246.7% margin

Operating Income

-$16M-357.6% margin

Net Income

-$15M-337.2% margin

EPS (Diluted)

$-0.31

QoQ Revenue Growth

-32.6%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$12M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$418M

Total Liabilities

$115M

Stockholders' Equity

$304M

Cash & Equivalents

$14M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$7M	-40.2%
Gross Profit	-$11M	-$3M	-284.8%
Operating Income	-$16M	-$7M	-130.5%
Net Income	-$15M	-$6M	-128.7%